LIGAND PHARMACEUTICALS INCORPORATED Unamortized Debt Issuance Expense
LIGAND PHARMACEUTICALS INCORPORATED (LGNZZ) had Unamortized Debt Issuance Expense of $0 as of 2015-12-31, per its 10-K filed 2016-11-14.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:UnamortizedDebtIssuanceExpense · last filed 2016-11-14
- 2015-12-31: Unamortized Debt Issuance Expense $0.00; Unamortized Debt Issuance Expense as first filed $2.53M.
- 2015-09-30: Unamortized Debt Issuance Expense $2.75M.
- 2015-06-30: Unamortized Debt Issuance Expense $2.96M.
- 2015-03-31: Unamortized Debt Issuance Expense $3.18M.
| Period end | Unamortized Debt Issuance Expense | Unamortized Debt Issuance Expense as first filed |
|---|---|---|
| 2015-12-31 | $0.00 10-K · filed 2016-11-14 | $2.53M 10-K · filed 2016-02-26 |
| 2015-09-30 | $2.75M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $2.96M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $3.18M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $3.39M 10-K · filed 2016-11-14 | |
| 2014-09-30 | $3.60M 10-Q · filed 2014-10-31 | |
| 2013-12-31 | $0.00 10-K · filed 2015-02-23 |